Abstract
The most common cause of megaloblastic anemia is deficiency of Vitamin B12 or folate. Its diagnosis is challenging, and for effective management, it is important to differentiate it from the other conditions which present with macrocytic anemia such as myelodysplasia, liver disease, hypothyroidism, etc. In this chapter, a clinical case scenario is presented followed by a step-by-step evidence-based approach to utilize specialized and advanced tests to unravel final diagnosis of megaloblastic anemia. A comprehensive description of pathophysiology of disease, the sensitivity and specificity of anti-intrinsic factor and anti-parietal cell antibodies, situations under which methylmalonyl-CoA (MMA) and homocysteine (HC) tested, importance of the transcobalamins in B12 metabolism and tests to monitor response to B12 therapy are discussed in question–answer format. Salient points are summarized for quick revision? To gain expertise on this topic and enhance your skills for effective planning of management, read this chapter on megaloblastic anemia.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Savage DG, Ogundipe A, Allen RH, Stabler SP, Lindenbaum J. Etiology and diagnostic evaluation of macrocytosis. Am J Med Sci. 2000;319(6):343–52.
Aslinia F, Mazza JJ, Yale SH. Megaloblastic anemia and other causes of macrocytosis. Clin Med Res. 2006;4(3):236–41.
Dali-Youcef N, Andres E. An update on cobalamin deficiency in adults. QJM. 2009;102(1):17–28.
Al Absi HS, Sacharow S, Al Zein N, et al. Hereditary orotic aciduria (HOA): a novel uridine-5-monophosphate synthase (UMPS) mutation. Mol Genet Metab Rep. 2021;26:100703. https://doi.org/10.1016/j.ymgmr.2020.100703.
Cakmakli HF, Torres RJ, Menendez A, et al. Macrocytic anemia in Lesch-Nyhan disease and its variants. Genet Med. 2019 Feb;21(2):353–60. https://doi.org/10.1038/s41436-018-0053-1.
Torrez M, Chabot-Richards D, Babu D, Lockhart E, Foucar K. How I investigate acquired megaloblastic anemia. Int J Lab Hematol. 2022;44:236–47.
Khera S, Pramanik SK, Patnaik SK. Transcobalamin deficiency: vitamin B12 deficiency with normal serum B12 levels. BMJ Case Rep. 2019;30:12.
Lindenbaum J, Savage DG, Stabler SP, Allen RH. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol. 1990;34(2):99–107.
Devalia V, Hamilton MS, Molloy AM, British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166(4):496–513. https://doi.org/10.1111/bjh.12959.
Kundrapu S, Noguez J. Laboratory assessment of anemia. Adv Clin Chem. 2018;83:97–225.
Carmel R. Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II. Am J Clin Nutr. 2011;94:348S–58S.
Lee S-M, Jongwon O, Chun M-R, Lee S-Y. Methylmalonic acid and homocysteine as indicators of vitamin B12 deficiency in patients with gastric cancer after gastrectomy. Nutrients. 2019;11(2):450. https://doi.org/10.3390/nu11020450.
Varela-Moreiras G, Murphy MM, Scott JM. Cobalamin, folic acid, and homocysteine. Nutr Rev. 2009;67(1):S 69-72.
Höegenauer C, Hammer HF. Maldigestion and malabsorption. In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger and Fordtran’s gastrointestinal and liver disease. 11th ed. Philadelphia: Elsevier; 2021: chap 104.
Nickoloff E. Schilling test: physiologic basis for and use as a diagnostic test. Crit Rev Clin Lab Sci. 1988;26(4):263–76.
Zuckier LS, Chervu LR. Schilling evaluation of pernicious anemia: current status. J Nucl Med. 1984;25(9):1032–9.
Das B, Bhatia SY, Pal BM. Comparison of diagnostic accuracy of active B12 (holotranscobalamin) and total vitamin B12 (cobalamin) and verification of active B12 test. Ind J Med Biochem. 2020;24(1):25–31.
Stabler SP. Vitamin B12. In: Marriott BP, Birt DF, Stallings VA, Yates AA, editors. Present knowledge in nutrition. 11th ed. Washington, DC: Elsevier; 2020. p. 257–71.
Green R. Vitamin B12 deficiency from the perspective of a practicing hematologist. Blood. 2017;129(19):2603–11.
Hoffbrand AV, Jackson BF. Correction of the DNA synthesis defect in vitamin B12 deficiency by tetrahydrofolate: evidence in favour of the methyl-folate trap hypothesis as the cause of megaloblastic anaemia in vitamin B12 deficiency. Br J Haematol. 1993;83(4):643–7.
Hesdorffer CS, Longo DL. Drug-induced megaloblastic anemia. N Engl J Med. 2015;373(17):1649–58.
Van Duijnhoven HL, Treskes M. Marked interference of hyperglycemia in measurements of mean (red) cell volume by Technicon H analyzers. Clin Chem. 1996;42(1):76–80.
Francis DA, Francis JL, Roath OS. Improved assessment of haemoglobin and red cell indices in blood samples with high white cell counts. Med Lab Sci. 1985;42(3):285–6.
Mohamed M, Thio J, Thomas RS, Philips J. Pernicious anemia. BMJ. 2020;369:m1319.
Andrès E, Serraj K. The pathophysiology of elevated vitamin B12 in clinical practice. QJM. 2013;106(6):505–15.
Carmel R. How I treat cobalamin (vitamin B12) deficiency. Blood. 2008;112(6):2214–21. https://doi.org/10.1182/blood-2008-03-040253.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Gupta, A. (2024). Megaloblastic Anemia. In: Decision Making Through Problem Based Learning in Hematology . Springer, Singapore. https://doi.org/10.1007/978-981-99-8933-1_2
Download citation
DOI: https://doi.org/10.1007/978-981-99-8933-1_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-8932-4
Online ISBN: 978-981-99-8933-1
eBook Packages: MedicineMedicine (R0)